Literature DB >> 2479470

Identification by monoclonal antibodies of an antigen shed by human bladder cancer cells.

M Liebert1, G A Wedemeyer, J A Stein, R W Washington, A Flint, L Q Ren, H B Grossman.   

Abstract

The reactivities of two anti-bladder cancer monoclonal antibodies, AN43 and BB369, were characterized. AN43 and BB369 reacted with a majority (greater than 50%) of bladder cancer tissue sections tested by immunoperoxidase staining. When tested against a panel of 27 normal human tissues, AN43 and BB369 reacted only with urothelium and stomach. AN43 and BB369 showed identical binding patterns and competed for binding on bladder cancer cells, suggesting that the two antibodies react with identical or spatially close epitopes. Bound BB369 antibody was rapidly shed from the surface of viable UM-UC-9 human bladder cancer cells. The antigen was found in spent tissue culture medium from the UM-UC-9 human bladder cancer cell line. AN43 and BB369 define a shed bladder tumor-associated antigen with limited distribution on normal tissues. The antigen is different from bladder tumor-associated antigens defined by other monoclonal antibodies and may be useful for the diagnosis and follow-up of patients with bladder cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479470

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

Review 1.  Challenges in development of targeted liposomal therapeutics.

Authors:  Rupa R Sawant; Vladimir P Torchilin
Journal:  AAPS J       Date:  2012-03-14       Impact factor: 4.009

2.  Expression of the VLA beta 1 integrin family in bladder cancer.

Authors:  M Liebert; R Washington; J Stein; G Wedemeyer; H B Grossman
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

3.  Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression.

Authors:  Stephanie Tseng-Rogenski; Jason Gee; Kathleen Woods Ignatoski; Lakshmi P Kunju; Amanda Bucheit; Hallie J Kintner; David Morris; Christopher Tallman; Joshua Evron; Christopher G Wood; H Barton Grossman; Cheryl T Lee; Monica Liebert
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

Review 4.  Alternatives to cytology in the management of non-muscle invasive bladder cancer.

Authors:  Gilad E Amiel; Tung Shu; Seth P Lerner
Journal:  Curr Treat Options Oncol       Date:  2004-10

5.  Loss of co-localization of alpha 6 beta 4 integrin and collagen VII in bladder cancer.

Authors:  M Liebert; R Washington; G Wedemeyer; T E Carey; H B Grossman
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

6.  Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody.

Authors:  Yongjun Yin; Xiaodi Ren; Craig Smith; Qianxu Guo; Maria Malabunga; Ilhem Guernah; Yiwei Zhang; Juqun Shen; Haijun Sun; Nabil Chehab; Nick Loizos; Dale L Ludwig; David M Ornitz
Journal:  Dis Model Mech       Date:  2016-04-07       Impact factor: 5.758

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.